Efficacy and Safety Outcomes with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Type 1 Diabetes According to Glycemic Variability-ONWARDS 6 Post Hoc Analysis

被引：0
|
作者：
Irace, Concetta
Begtrup, Kamilla
Marques, Mariana Fragao
Watt, Sara K.
Klonoff, David C.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1882-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1882-LB
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Superior Glycemic Control with Once-Weekly Insulin Icodec with a Dosing Guide App vs. Once-Daily (OD) Basal Insulin Analogs in Insulin-Naive T2D-ONWARDS 5
    Bajaj, Harpreet S.
    Aberle, Jens
    Davies, Melanie J.
    Donatsky, Anders M.
    Frederiksen, Marie
    Yavuz, Dilek Gogas
    Gowda, Amoolya
    Lingvay, Ildiko
    Bode, Bruce W.
    DIABETES, 2023, 72
  • [22] Improved patient-reported outcomes with once-weekly insulin icodec with a dosing guide app versus once-daily basal insulin analogues in type 2 diabetes (ONWARDS 5)
    Goldenberg, R.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Polonsky, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S398
  • [23] Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) A Randomized Trial
    Bajaj, Harpreet S.
    Aberle, Jens
    Davies, Melanie
    Donatsky, Anders Meller
    Frederiksen, Marie
    Yavuz, Dilek G.
    Gowda, Amoolya
    Lingvay, Ildiko
    Bode, Bruce
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : 1476 - 1485
  • [24] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [25] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [26] Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
    Saleem, Syed Zia
    Fareed, Areeba
    Akhtar, Syed Muhammad Muneeb
    Farhat, Solay
    Taha, Amira Mohamed
    Akilimali, Aymar
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [27] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 Diabetes
    Takamura, Toshinari
    Miyagawa, Jun-Ichiro
    Odawara, Masato
    Takita, Yasushi
    Iwamoto, Noriyuki
    Imaoka, Takeshi
    DIABETES, 2015, 64 : A285 - A285
  • [28] Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
    Syed Zia Saleem
    Areeba Fareed
    Syed Muhammad Muneeb Akhtar
    Solay Farhat
    Amira Mohamed Taha
    Aymar Akilimali
    Diabetology & Metabolic Syndrome, 16
  • [29] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [30] Efficacy and safety of once-weekly insulin icodec in type 2 diabetes: A meta-analysis of ONWARDS phase 3 randomized controlled trials
    Shetty, Sahana
    Suvarna, Renuka
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 1069 - 1081
12345